Market Focus: Trading Strategies for Jubilant Pharmova, Linde India, Emcure Pharma, Granules, Ather Energy, and Other Stocks on March 25

Indian Equity Market Sees Relief Rally

On March 24, Indian equity benchmarks experienced a relief rally of approximately 1.8%, driven by improved market breadth. A total of 2,315 shares saw buying interest, compared to 695 declining shares on the National Stock Exchange (NSE).

Short-Term Trading Ideas

Jubilant Pharmova

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

• CMP: Rs 860.35
• Strategy: Buy
• Target: Rs 910, Rs 945
• Stop-Loss: Rs 852

Jubilant Pharmova has emerged as a strong outperformer in the pharma sector, gaining 12% over the past three weeks. The stock has been consolidating in the Rs 786–862 range and has closed above the middle Bollinger Band, indicating improving momentum.

Linde India

• CMP: Rs 7,393.5
• Strategy: Buy
• Target: Rs 7,815, Rs 8,050
• Stop-Loss: Rs 7,210

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Linde India posted a strong gain of over 9% in the previous session, supported by a sharp rise in volumes. The stock has broken above the upper Bollinger Band, reflecting strengthening momentum.

Emcure Pharmaceuticals

• CMP: Rs 1,539.7
• Strategy: Buy
• Target: Rs 1,585, Rs 1,680
• Stop-Loss: Rs 1,510

Emcure Pharma has displayed strong relative outperformance by holding steady in a weak market environment. The stock took support near the Rs 1,443 zone and witnessed a sharp bounce, gaining over 4.5% while closing above the previous three sessions' high.

Granules India

• CMP: Rs 606.35
• Strategy: Buy
• Target: Rs 636
• Stop-Loss: Rs 585

Granules India has exhibited a symmetrical triangle pattern and has broken out with rising volumes. The stock is consistently trading above all its major exponential moving averages, establishing a strong uptrend.

Ather Energy

• CMP: Rs 757
• Strategy: Buy
• Target: Rs 830
• Stop-Loss: Rs 706

Ather Energy broke out of a consolidation phase and has been sustaining above it since then. This breakout was supported by an expansion in volumes, and the stock is consistently trading above all its major exponential moving averages, confirming a strong uptrend.

DLF

• CMP: Rs 521
• Strategy: No recommendation
• Target: No target
• Stop-Loss: No stop-loss

DLF has been in a clear downtrend, forming lower highs and lower lows. The stock has been consistently trading below all major EMAs, indicating bearish price action.